All Articles

A new model called 'Guest Experience Architecture' and its enabling platform, Artuzan, aim to shift luxury hospitality from transactions to lasting relationships.

Sisram Medical's strategic rollout of advanced devices and injectables in Thailand is more than an expansion; it's a calculated move to dominate APAC's booming beauty market.

Sinda Ltd. launches a major IPO to mine vast Mexican silver reserves. Can it navigate local hurdles to supply the booming solar and EV industries?

A community run born from tragedy now serves as a model for sustained, collective action against a documented rise in racial and religious intolerance.

A Canadian security firm's new US hub is more than an expansion. It's a high-stakes play to fix a hidden vulnerability at the heart of our critical infrastructure.

MapLight's Phase 2 trial for ASD missed its primary goal, but a powerful signal in reducing irritability in teens could reshape its future and offer a safer alternative.

A single drug receptor could treat cancer, psoriasis, and liver disease. Can-Fite’s new scientific validation boosts its platform, but clinical and financial hurdles loom.

Little Caesars’ new Spider-Man partnership is more than a pizza promotion; it's a calculated bid for cultural supremacy in the fast-food wars.

As private credit pulls back, PropTech firm Gumption expands its tech-driven financing platform to the West Coast, betting on a seasoned expert to succeed.

A new partnership embeds Gemini AI into Nokia's software, promising to cut network issues by 80%. But what does "glass box autonomy" mean for investors?

With a key NSF grant and promising large-animal data, Endure Biotherapeutics' engineered 'native' bacteria may rewrite the playbook for PKU and beyond.

XTEL's new SAP Store integration dissolves the trade-off between deep ERP integration and best-in-class tools, deploying agentic AI to reshape CPG profitability.

Chain's new AI agent automates the complex, conversational dance of freight booking. It's a move that promises not to replace brokers, but to redefine their role.

With new funding from top VCs, DropGenie is shrinking gene editing to power the next wave of AI-driven drug discovery using precious patient cells.

Polaris appoints Sealed Air CEO Dustin Semach to its board, a move signaling a calculated pivot towards technology and financial rigor in its powersports strategy.

A new high-tech distribution center in Italy reveals the strategy for modern market dominance: a fusion of aggressive retail expansion and radical sustainability.

SKS's new Boston Technicurean Center isn't just a showroom; it's a destination. Explore how this partnership is changing how we design, buy, and live.

A new AI platform, born from its founder's own cancer battle, aims to give patients the tools to navigate complex treatments and advocate for their own care.

A Chinese AI innovator and a new European biotech just sealed a massive deal. It’s a blueprint for the future of medicine, where technology and strategy unite for patients.